Persistent Neutrophil to Lymphocyte Ratio >3 during Treatment with Enzalutamide and Clinical Outcome in Patients with Castration-Resistant Prostate Cancer.

PLoS One · 2016 · PMC4951050 · PMID 27434372

Europe PMC DOI

hedged sentence

0.0790

closest p · 1.6× alpha

0.0790

boldest claim

The sentences

of borderline significancep = 0.079so close (0.05 < p ≤ 0.1)

Similar results were also observed for OS for NLR after 4 weeks: HR 1.29 (95% CI 1.10–1.51) ( p = 0.001), whereas were of borderline significance for NLR after 12 weeks: HR 1.09 (95% CI 0.99–1.20) ( p = 0.079).

also in 1,677 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.